欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/3984/001
药品名称Everolimus Mylan 2.5 mg tablets
活性成分
    • Everolimus 2.5 mg
剂型Tablet
上市许可持有人Mylan Pharmaceuticals Limited Damastown Industrial Park, Mulhuddart D15 XD71, Dublin 15 Ireland
参考成员国 - 产品名称Netherlands (NL)
Everolimus Mylan 2,5 mg, tabletten
互认成员国 - 产品名称
    • Germany (DE)
      Everolimus Mylan 2,5 mg Tabletten
    • Denmark (DK)
      Everolimus Mylan
    • United Kingdom (Northern Ireland) (XI)
    • France (FR)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Bulgaria (BG)
      Everolimus Mylan
    • Croatia (HR)
      Everolimus Mylan 2,5 mg tablete
许可日期2018/05/30
最近更新日期2024/09/11
药物ATC编码
    • L01XE10 everolimus
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase